BE855232A - Solution stabilisee d'aminophylline et procede de sa preparation - Google Patents

Solution stabilisee d'aminophylline et procede de sa preparation

Info

Publication number
BE855232A
BE855232A BE178067A BE178067A BE855232A BE 855232 A BE855232 A BE 855232A BE 178067 A BE178067 A BE 178067A BE 178067 A BE178067 A BE 178067A BE 855232 A BE855232 A BE 855232A
Authority
BE
Belgium
Prior art keywords
stabilized
preparation
aminophylline
aminophylline solution
solution
Prior art date
Application number
BE178067A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BE855232A publication Critical patent/BE855232A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
BE178067A 1976-06-01 1977-05-31 Solution stabilisee d'aminophylline et procede de sa preparation BE855232A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/691,269 US4073907A (en) 1976-06-01 1976-06-01 Stabilized aminophylline solution and process therefor

Publications (1)

Publication Number Publication Date
BE855232A true BE855232A (fr) 1977-11-30

Family

ID=24775842

Family Applications (1)

Application Number Title Priority Date Filing Date
BE178067A BE855232A (fr) 1976-06-01 1977-05-31 Solution stabilisee d'aminophylline et procede de sa preparation

Country Status (9)

Country Link
US (1) US4073907A (fr)
AU (1) AU513283B2 (fr)
BE (1) BE855232A (fr)
CA (1) CA1084842A (fr)
DE (1) DE2724499A1 (fr)
ES (1) ES459357A1 (fr)
FR (1) FR2353553A1 (fr)
GB (1) GB1553765A (fr)
PH (1) PH13283A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO800460L (no) * 1979-02-21 1980-08-22 Research Corp Fremgangsmaate ved fremstilling av teofyllinderivat
WO2003022239A2 (fr) * 2001-09-07 2003-03-20 Western Holdings Llc Emulsions eau dans l'huile stables contenant de l'aminophylline
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
CN101361742B (zh) * 2008-10-06 2011-01-19 重庆健能医药开发有限公司 一种氨茶碱口服溶液及其制备方法
CN114939393A (zh) * 2022-06-01 2022-08-26 青岛科技大学 一种连续化生产氨茶碱的系统及方法

Also Published As

Publication number Publication date
CA1084842A (fr) 1980-09-02
DE2724499A1 (de) 1977-12-15
AU2444677A (en) 1978-10-26
AU513283B2 (en) 1980-11-27
PH13283A (en) 1980-02-29
GB1553765A (en) 1979-10-10
US4073907A (en) 1978-02-14
FR2353553A1 (fr) 1977-12-30
ES459357A1 (es) 1978-08-01

Similar Documents

Publication Publication Date Title
FR2342981A1 (fr) Procede de preparation d'hydrogenosilanes
FR2304601A1 (fr) Procede d'ammonoxydation
BE861172A (fr) Procede de preparation d'alpha-amino-amides
BE855682A (fr) Procede d'encapsulement
FR2349602A1 (fr) Procede perfectionne d'obtention de 7-ceto-5-steroides
BE858576A (fr) Procede de preparation d'ethers
FR2299769A1 (fr) Procede d'application
FR2305416A1 (fr) Procede de preparation de tricosene-(9) et d'heneicosene-(9)
RO73519A (fr) Procede d'obtention des corticoides
FR2353553A1 (fr) Solution stabilisee d'aminophylline et procede de sa preparation
BE861107A (fr) P-isobutyl-hydratropate de gaiacol et procede pour sa preparation
BE854688A (fr) Procede d'epuration
FR2300398A1 (fr) Procede d'aplatissement de la courbe d
BE852148A (fr) Procede de production d'hydrazobenzenes
RO74589A (fr) Procede de preparation des ethers oxymiques de l'isonitrozovyanacetamide
BE854473A (fr) Procede de preparation catalytique de l'acrylonitrile
BE852700R (fr) Procede de preparation d'oxaphospholannes-1,2
FR2343753A1 (fr) Procede de preparation d'alcali-cellulose
BE855037R (fr) Procede d'ammonoxydation
FR2344535A1 (fr) 2-oxo-1-pyrrolidines et leur procede d'obtention
BE855125A (fr) Procede de preparation d'ethylene-glycol
FR2321974A1 (fr) Procede d'ecriquage
BE851372A (fr) Nouvelles propylenediamides et leur procede d'obtention
BE859529A (fr) Procede de preparation de n1(2'-furannidyl)-5-fluoro-uracile
BE857738A (fr) Procede de preparation d'alkylphosphines